Bibliographic Details
| Title: |
'Old is gold' does conventional test tube method still reign supreme? An immuno‐haematological survey of anti‐D detection and titration in ante‐natal cases among major hospitals across India. |
| Authors: |
Pandey, Prashant1 (AUTHOR), Marik, Arghyadeep1 (AUTHOR) marik5441@gmail.com, Tiwari, Aseem2 (AUTHOR), Das, Sudipta Shekhar3 (AUTHOR), Shastry, Shamee4 (AUTHOR), Chowdhry, Mohit5 (AUTHOR), Kumari, Supriya1 (AUTHOR) |
| Source: |
Transfusion Medicine. Aug2024, Vol. 34 Issue 4, p278-286. 9p. |
| Subject Terms: |
*ERYTHROBLASTOSIS fetalis, *BLOOD transfusion, *MEDICAL specialties & specialists, *TERTIARY care, *VOLUMETRIC analysis |
| Abstract: |
Introduction: Anti‐D detection and titration plays a major role in RhD negative antenatal cases both, for monitoring maternal as well as fetal status as well as initiation of early therapeutic interventions, such as intra‐uterine transfusions (IUT) to improve maternal as well as fetal morbidity and mortality and reduce the adverse effects of haemolytic disease of fetus and newborn (HDFN). We conducted a survey focusing on the policies and procedures of anti‐D detection and titration among major tertiary care centres across India. Methodology: The survey was drafted by a working group of transfusion medicine and immunohematology specialists from six different centres in India. Data were obtained via the use of an online questionnaire. Results: Results were categorised into four categories, Hospital information, immuno‐haematological testing methodology, clinical significance of anti‐D testing and the role of transfusion medicine specialists. The survey highlighted the modalities as well as the methodologies of anti‐D detection and titration in antenatal women across different major tertiary care centres in India. Conclusion: This survey provided a unique snapshot of the prevalent methodologies being employed by major tertiary care centres across the country for detection and titration of anti‐D levels as well as the important role it plays in the therapy of affected antenatal women to minimise adverse effects on the fetus. [ABSTRACT FROM AUTHOR] |
|
Copyright of Transfusion Medicine is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
